Patents by Inventor Aimee D. Reed

Aimee D. Reed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7119112
    Abstract: Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through voltage-dependent potassium channels. More particularly, the invention provides sulfonamides, and compositions and methods utilizing sulfonamides that are useful in the treatment of diseases by blocking potassium channels associated with the onset or recurrence of the indicated conditions. Exemplary diseases treatable with the compounds, compositions and methods of the invention include sickle cell disease and glaucoma.
    Type: Grant
    Filed: August 14, 2003
    Date of Patent: October 10, 2006
    Assignee: ICAgen, Inc.
    Inventors: Grant A. McNaughton-Smith, Aimee D. Reed, Robert N. Atkinson
  • Patent number: 6858610
    Abstract: Compounds as potassium channel inhibitors and especially useful for the treatment of cardiac arrhythmias and cell proliferative disorders are described.
    Type: Grant
    Filed: August 2, 2002
    Date of Patent: February 22, 2005
    Assignee: ICAgen, Inc.
    Inventors: Michael Gross, Serge Beaudoin, Aimee D. Reed
  • Patent number: 6849634
    Abstract: Compounds useful as potassium channel inhibitors and especially useful for the treatment of cardiac arrhythmias and cell proliferative disorders are described.
    Type: Grant
    Filed: December 7, 2001
    Date of Patent: February 1, 2005
    Assignee: ICAgen
    Inventors: Serge Beaudoin, Aimee D. Reed, Michael F. Gross
  • Publication number: 20040106613
    Abstract: Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through voltage-dependent potassium channels. More particularly, the invention provides sulfonamides, and compositions and methods utilizing sulfonamides that are useful in the treatment of diseases by blocking potassium channels associated with the onset or recurrence of the indicated conditions. Exemplary diseases treatable with the compounds, compositions and methods of the invention include sickle cell disease and glaucoma.
    Type: Application
    Filed: August 14, 2003
    Publication date: June 3, 2004
    Applicant: Icagen, Inc.
    Inventors: Grant A. McNaughton-Smith, Aimee D. Reed, Robert N. Atkinson
  • Patent number: 6620849
    Abstract: Compounds which are useful as potassium channel inhibitors and which because of their slow off-rates are especially useful for the treatment of cardiac arrhythmias are described.
    Type: Grant
    Filed: July 24, 2001
    Date of Patent: September 16, 2003
    Assignee: ICAFEN, Inc.
    Inventors: Serge Beaudoin, Michael F. Gross, Aimee D. Reed, Alan D. Wickenden, Anrou Zou
  • Publication number: 20030013706
    Abstract: Compounds useful as potassium channel inhibitors and especially useful for the treatment of cardiac arrhythmias and cell proliferative disorders are described.
    Type: Application
    Filed: August 2, 2002
    Publication date: January 16, 2003
    Applicant: ICAgen
    Inventors: Michael Gross, Serge Beaudoin, Aimee D. Reed
  • Publication number: 20020169161
    Abstract: Compounds which are useful as potassium channel inhibitors and which because of their slow off-rates are especially useful for the treatment of cardiac arrhythmias are described.
    Type: Application
    Filed: July 24, 2001
    Publication date: November 14, 2002
    Inventors: Serge Beaudoin, Michael F. Gross, Aimee D. Reed, Alan Wickenden, Anrou Zou
  • Publication number: 20020161011
    Abstract: Compounds useful as potassium channel inhibitors and especially useful for the treatment of cardiac arrhythmias and cell proliferative disorders are described.
    Type: Application
    Filed: December 7, 2001
    Publication date: October 31, 2002
    Applicant: ICAgen
    Inventors: Serge Beaudoin, Aimee D. Reed, Michael F. Gross
  • Patent number: 6458794
    Abstract: Compounds useful as potassium channel inhibitors and especially useful for the treatment of cardiac arrhythmias and cell proliferative disorders are described.
    Type: Grant
    Filed: December 21, 2000
    Date of Patent: October 1, 2002
    Assignee: Icagen, Inc.
    Inventors: Michael Gross, Serge Beaudoin, Aimee D. Reed